Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3764118017 | Asparaginase (as crisantaspase) 10000 unit powder for solution for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3764119013 | Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
46728301000001111 | Crisantaspase 10,000unit powder for solution for injection vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing asparaginase | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | L-asparaginase | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing crisantaspase (medicinal product) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | Crisantaspase | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing asparaginase in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Crisantaspase | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit | Vial | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | Unit | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | Asparaginase | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 10000 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing only crisantaspase in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | Asparaginase | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Subcutaneous route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutioninjection.intravenous ontology form and route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutioninjection.subcutaneous ontology form and route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutioninjection.intramuscular ontology form and route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Intramuscular route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Intravenous route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | Asparaginase | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has specific active ingredient | Asparaginase | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has dispensed dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Has specific active ingredient | Crisantaspase | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Crisantaspase 10,000iu injection (pdr for recon) - product | Is a | False | Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier | |
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) | Is a | False | Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier | |
Crisantaspase 10,000unit powder for solution for injection vials 5 vial | Is pack of | False | Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier | |
Crisantaspase 10,000unit powder for solution for injection vials 20 vial | Is pack of | False | Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier | |
Crisantaspase 10,000unit powder for solution for injection vials 5 vial | Has VMP | False | Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier | |
Crisantaspase 10,000unit powder for solution for injection vials 20 vial | Has VMP | False | Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets